A new system that can predict a proposed drug’s chemical structure could help prevent adverse drug interactions, one of the leading causes of patient death.
Why it matters: According to the FDA, serious adverse drug interactions could kill more than 100,000 hospitalized people in the US every year. But traditional ways of avoiding such interactions during drug development require expensive and laborious physical testing and clinical trials to catalogue all the proposed drug’s possible chemical interactions with existing ones.
How it works: The system takes in two different drugs and generates a prediction for how or whether they will interact. To get there, the researchers first translated the 3D chemical structures of drugs into a character format known as SMILES that could be read by a neural network. The drug melatonin, for example, is represented by “CC(=O)NCCC1=CNc2c1cc(OC)cc2,” while morphine is represented by “CN1CCC23C4OC5=C(O)C=CC(CC1C2C=CC4O)=C35.”
They then trained a neural network on a database of known drug interactions. The resulting system predicts the probability that two drugs will have an adverse interaction and shows the particular parts of the molecule that contributed to that prediction.
The results: When the researchers tested their system on two common drug interaction data sets, it performed better than state-of-the-art results from existing AI systems. The paper, which was led by researchers at health information technology company IQVIA, is being presented at the proceedings of the Association for the Advancement of Artificial Intelligence later this week.
Co-pilot: The new techniques for analyzing chemical data could have many other applications, including drug and material design. “There's just an awful lot of the modern world that depends on chemistry,” says David Cox, the IBM director of the MIT-IBM Watson AI Lab, a member of which coauthored the paper. “There’s tremendous potential for AI to be a copilot for us, augmenting our ability to reason about chemical interactions, properties, and qualities.”
Correction: An earlier version of this article misstated David Cox‘s title as director and SMILES as a new convention. The article has since been updated.
To have more stories like this delivered directly to your inbox, sign up for our Webby-nominated AI newsletter The Algorithm. It's free.
DeepMind’s cofounder: Generative AI is just a phase. What’s next is interactive AI.
“This is a profound moment in the history of technology,” says Mustafa Suleyman.
Deepfakes of Chinese influencers are livestreaming 24/7
With just a few minutes of sample video and $1,000, brands never have to stop selling their products.
AI hype is built on high test scores. Those tests are flawed.
With hopes and fears about the technology running wild, it's time to agree on what it can and can't do.
You need to talk to your kid about AI. Here are 6 things you should say.
As children start back at school this week, it’s not just ChatGPT you need to be thinking about.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.